Lobbying

Capital RX's latest lobbying report covers Q2 2026, at $50K. The four quarters Q4 2025–Q3 2026 total $150K. Its first report covers Q2 2023; the issues it reports most are Pharmacy.

Capital RX

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$150K
Last 4 quarters
vs last quarter
−100.0%
Q3 2026 against the quarter before
First report
Q2 2023
The first quarter a report named it

Lobbying by quarter

Capital RX lobbying by quarter
Capital RX lobbying by quarter
QuarterAmountReports
Q2 2023$20K1
Q3 2023$50K1
Q4 2023$50K1
Q1 2024$50K1
Q2 2024$50K1
Q3 2024$50K1
Q4 2024$50K1
Q1 2025$50K1
Q2 2025$50K1
Q3 2025$50K1
Q4 2025$50K1
Q1 2026$50K1
Q2 2026$50K1
Q3 2026$00

By issue

  • Pharmacy$620K · 13 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • HOUSE OF REPRESENTATIVES13 reports
  • SENATE13 reports
  • Centers For Medicare and Medicaid Services (CMS)11 reports
  • White House Office2 reports

Firms it paid

Firm
Mason Street Consulting$620K13 quarters

Former officials lobbying for it

Former position
SUSAN S ZOOKLegislative Assistant, Senator Mike Crapo; Legislative Assistant, Representative Charlie Dent; Legislative Correspondent/Staff Assistant, Representative Tim MurphyQ2 2026

Lobbying reports

Filed by
07/07for Q2Mason Street Consulting$50K
04/02for Q1Mason Street Consulting$50K
01/18for Q4 2025Mason Street Consulting$50K
25/10/06for Q3 2025Mason Street Consulting$50K
25/07/08for Q2 2025Mason Street Consulting$50K
25/04/10for Q1 2025Mason Street Consulting$50K
25/01/10for Q4 2024Mason Street Consulting$50K
24/10/07for Q3 2024Mason Street Consulting$50K
24/07/07for Q2 2024Mason Street Consulting$50K
24/04/09for Q1 2024Mason Street Consulting$50K
24/01/09for Q4 2023Mason Street Consulting$50K
23/10/18for Q3 2023Mason Street Consulting$50K
23/07/20for Q2 2023Mason Street Consulting$20K
23/07/16for Q2 2023Mason Street ConsultingUnder $5,000